MedicaidCoverageMedium impact
2025.15 - Provider Bulletin - Policy Updates and Changes to Clinical Review Criteria - Revised 04.28.2025
Connecticut Medicaid (HUSKY Health)·CT · Hematology, Oncology, Dermatology +4 more·Provider Bulletin
Effective date
May 1, 2025
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid (CMAP) is implementing new coverage policies for gene therapies and laser therapy, retiring policies for discontinued treatments, and updating criteria for durable medical equipment and various medical services effective May 1, 2025.
Action Required
By May 1, 2025: Billing team must review updated prior authorization requirements for new gene therapies (TheraBionic P1, Beqvez, Hemgenix, Zynteglo, Casgevy, Lyfgenia) and laser therapy services. Stop submitting claims for discontinued Zulresso treatment. Update prior authorization workflows for affected durable medical equipment including hospital beds, walkers, protective helmets, and bathing equipment. Access updated policies at https://portal.ct.gov/husky under Medical Management guidelines.